Cocrystal Pharma (COCP)

• Market cap: $14.6M
• 1 day: -2.83%
• 5 days: -0.96%
• 1 month: 7.29%
• 3 months: -0.96%
• 6 months: -29.45%
• Year to date: 3.75%
• 1 year: -41.48%
• 5 years: -93.78%
• 10 years: -98.19%
• Sector: Healthcare
• Industry: Biotechnology

About: Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Employees: 11